Pfizer (PFE) Reduces FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $28.07 +1.01%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) lowers its FY12 adj-EPS guidance from $2.25-$2.35 to $2.20-$2.30, which compares to the Street estimate of $2.30.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ocean Power Technologies revises fiscal 2026 results after audit
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
